National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

allogeneic dendritic cell-myeloma idiotype vaccine
A cell-based vaccine composed of allogeneic dendritic cells pulsed ex-vivo with an autologous myeloma idiotype with potential antineoplastic activity. Upon administration, allogeneic dendritic cell-myeloma idiotype vaccine may stimulate the host immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against myeloma cells, resulting in cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Previous:ALIMTA, alitretinoin, Alkeran, allogeneic B7.1/HLA-A1 transfected tumor cell vaccine, allogeneic CD4+ memory Th1-like T cells/microparticle-bound anti-CD3/anti-CD28
Next:allogeneic GM-CSF-secreting breast cancer vaccine, allogeneic large multivalent immunogen melanoma vaccine LP2307, allogeneic LMP1-/LMP2- specific cytotoxic T-lymphocytes, allogeneic melanoma vaccine AGI-101H, allogeneic multipotent adult progenitor cells